• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗引起的心脏并发症。

Cardiac complications from cancer therapy.

作者信息

Blaes Anne Hudson

机构信息

Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, USA.

出版信息

Minn Med. 2010 Oct;93(10):40-4.

PMID:21140761
Abstract

In 2005, more than 10 million people in the United States were cancer survivors, and that number is expected to grow as therapies for cancer improve and the population ages. Although survival is something to be celebrated, it can be accompanied by a number of health problems secondary to the initial disease and its treatment. Cardiovascular problems are emerging as a particular concern among the survivor population. This article reviews what is known about the kinds and rates of cardiovascular complications common to cancer survivors, the treatments that caused them, and the risk factors for them. It also presents guidance for primary care providers caring for survivors who may be at risk of cardiovascular complications.

摘要

2005年,美国有超过1000万人是癌症幸存者,随着癌症治疗方法的改进和人口老龄化,这一数字预计还会上升。虽然生存是值得庆贺的事,但它可能伴随着一系列继发于初始疾病及其治疗的健康问题。心血管问题正成为幸存者群体中特别令人担忧的问题。本文回顾了关于癌症幸存者常见心血管并发症的种类和发生率、导致这些并发症的治疗方法以及相关风险因素的已知情况。它还为照顾可能有心血管并发症风险的幸存者的初级保健提供者提供了指导。

相似文献

1
Cardiac complications from cancer therapy.癌症治疗引起的心脏并发症。
Minn Med. 2010 Oct;93(10):40-4.
2
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.老年乳腺癌患者的化疗与心脏毒性:一项基于人群的研究。
J Clin Oncol. 2005 Dec 1;23(34):8597-605. doi: 10.1200/JCO.2005.02.5841.
3
Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.超声心动图检查在接受蒽环类药物治疗的无症状儿童癌症幸存者中的应用:一项前瞻性随访研究。
Pediatr Blood Cancer. 2010 Apr;54(4):579-84. doi: 10.1002/pbc.22371.
4
Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.儿童癌症幸存者心血管疾病监测:儿童肿瘤学组心血管疾病特别工作组报告
Pediatrics. 2008 Feb;121(2):e387-96. doi: 10.1542/peds.2007-0575. Epub 2008 Jan 10.
5
Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.蒽环类药物引起的心脏毒性在体重不足的儿童癌症幸存者中更有可能出现。
J Pediatr Hematol Oncol. 2010 Jul;32(5):411-5. doi: 10.1097/MPH.0b013e3181dccd37.
6
Role of anthracyclines in the era of targeted therapy.蒽环类药物在靶向治疗时代的作用。
Cardiovasc Toxicol. 2007;7(2):56-60. doi: 10.1007/s12012-007-0015-3.
7
Survivorship: adult cancer survivors.生存:成年癌症幸存者。
Prim Care. 2009 Dec;36(4):721-41. doi: 10.1016/j.pop.2009.08.001.
8
Anthracycline cardiotoxicity in long-term survivors of childhood cancer.儿童癌症长期幸存者中的蒽环类药物心脏毒性
Cardiovasc Toxicol. 2007;7(2):122-8. doi: 10.1007/s12012-007-0006-4.
9
Predicting and preventing the cardiotoxicity of cancer therapy.预测和预防癌症治疗的心脏毒性。
Expert Rev Cardiovasc Ther. 2008 Aug;6(7):1023-33. doi: 10.1586/14779072.6.7.1023.
10
Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.接受蒽环类药物治疗的儿童癌症无症状长期存活者的NT-前脑钠肽水平异常。
Pediatr Blood Cancer. 2009 May;52(5):631-6. doi: 10.1002/pbc.21913.

引用本文的文献

1
Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment.接受辅助性乳腺癌治疗的女性中血管紧张素转换酶抑制剂(ACEI)与阿霉素的药代动力学
Springerplus. 2015 Jan 23;4:32. doi: 10.1186/s40064-015-0802-4. eCollection 2015.